Immune escape by Epstein–Barr virus associated malignancies
- 19 October 2008
- journal article
- review article
- Published by Elsevier in Seminars in Cancer Biology
- Vol. 18 (6), 381-387
- https://doi.org/10.1016/j.semcancer.2008.10.002
Abstract
No abstract availableKeywords
This publication has 99 references indexed in Scilit:
- Patients with Epstein Barr virus‐positive lymphomas have decreased CD4+ T‐cell responses to the viral nuclear antigen 1International Journal of Cancer, 2008
- Duration of Naturally Acquired Antibody Responses to Blood-StagePlasmodium falciparumIs Age Dependent and Antigen SpecificInfection and Immunity, 2008
- Phase I Trial of a CD8+T-Cell Peptide Epitope-Based Vaccine for Infectious MononucleosisJournal of Virology, 2008
- A role for AID in chromosome translocations between c-myc and the IgH variable regionThe Journal of Experimental Medicine, 2007
- Galectin-1 mediated suppression of Epstein-Barr virus–specific T-cell immunity in classic Hodgkin lymphomaBlood, 2007
- Primary CD4+T-Cell Responses Provide both Helper and Cytotoxic Functions during Epstein-Barr Virus Infection and Transformation of Fetal Cord Blood B CellsJournal of Virology, 2007
- Malaria hemozoin is immunologically inert but radically enhances innate responses by presenting malaria DNA to Toll-like receptor 9Proceedings of the National Academy of Sciences, 2007
- Increase in circulating Foxp3+CD4+CD25high regulatory T cells in nasopharyngeal carcinoma patientsBritish Journal of Cancer, 2007
- Three restricted forms of Epstein–Barr virus latency counteracting apoptosis in c-myc-expressing Burkitt lymphoma cellsProceedings of the National Academy of Sciences, 2006
- T-cell control of Epstein–Barr virus-infected B cells is lost during P. falciparum malariaNature, 1984